Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?

A S, Lubiniecki; P R, McAllister; T M, Smith; P J, Shadle

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1997

Data sources: Europe PubMed Central

Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?

descriptionPublicationkeyboard_double_arrow_right Article 23 Apr 1997 English Journal:Developments in biological standardization, volume 88 (issn: 0301-5149,

Copyright policy )

Authors: A S, Lubiniecki; P R, McAllister; T M, Smith; P J, Shadle;

pmid: 9119154

Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Biological Products, Virion, Reproducibility of Results, Sterilization, Viral Vaccines, CHO Cells, History, 20th Century, Risk Assessment, Retroviridae, Virus Diseases, Cricetinae, Animals, Humans, Drug Contamination

Impact byBIP!

	citations The total number of citations received by all articles of the researcher of interest.	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

2

Average

Upload OA version

Are you the author of this publication? Upload your Open Access version to Zenodo!

It’s fast and easy, just two clicks!

uploadUpload now